Network-Guided Theta Burst Stimulation for Breast Cancer With Chemotherapy-Induced Peripheral Neuropathy: Clinical and fMRI Biomarker Evidence
NCT07695415 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-07-10
Summary
Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating complication among breast cancer survivors, frequently associated with chronic neuropathic pain that remains inadequately controlled by pharmacological treatments. Emerging evidence suggests that CIPN pain is related to maladaptive reorganization of pain-related brain networks, highlighting the potential of non-pharmacological, brain-based neuromodulation strategies.
Among the variants of theta burst stimulation (TBS), both prolonged constant theta burst stimulation (pcTBS) and intermittent theta burst stimulation (iTBS) have facilitating effects of cortical excitability. The treatment time for pcTBS (1 min and 44 s, 1200 pulses) is much shorter than that of iTBS and traditional repetitive transcranial magnetic stimulation (rTMS); therefore, pcTBS seems to be a promising neuromodulation method for chronic pain and head-to-head comparison between pcTBS and iTBS has never been done before.
The aim of this two-year randomized, cross-over trial project is 1) to compare the effects of pcTBS and iTBS and determine the optimal TBS paradigm for alleviating CIPN pain a sequential focus on distinct cortical targets; 2) to implement a prospectively defined, network-guided framework using fMRI to characterize sensorimotor and pain-related brain connectivity and to examine whether baseline network features and stimulation-induced connectivity changes moderate clinical outcomes.
In Year 1, 20 breast cancer patients with CIPN will be recruited and randomly assigned to two groups: Group I will initially receive pcTBS over M1 for 5 consecutive days and then iTBS over M1 after a 8-week "wash-out" period. Group II will initially receive iTBS over M1 for 5 consecutive days and then pcTBS over M1 after a 8-week "wash-out" period. In year 2, the stimulation target will be changed to dorsolateral prefrontal cortex (DLPFC) to evaluate analgesic effects, and associated brain network changes related to cognitive-affective pain modulation.
MRI-based neuronavigation will be used to ensure precise and reproducible stimulation targeting. Both resting-state and task-based functional MRI will be acquired before stimulation and used prospectively to identify individualized pain-relevant cortical hotspots within predefined anatomical regions (M1 or DLPFC). Resting-state fMRI will be repeated within 24 hours after the final stimulation session to evaluate treatment-related changes in brain networks. Pain intensity measured by the visual analog scale will serve as the primary outcome, with secondary outcomes including Neuropathic Pain Symptom Inventory, Depression Anxiety Stress Scale 21 and pressure pain threshold testing. Primary and secondary outcomes will be evaluated immediately after the last stimulation session and again at 4-week follow-up.
By integrating a clinically efficient trial design with network-informed neuroimaging, this project is expected to provide target-specific evidence for TBS in CIPN pain and to establish a foundation for future precision-guided neuromodulation studies.
Conditions
- CIPN - Chemotherapy-Induced Peripheral Neuropathy
- Breast Cancer
Interventions
- OTHER
-
pcTBS
Intermittent TBS (iTBS) applies 2 s of TBS trains repeated every 10 s for a total of 20 cycles (600 pulses, total 190 s) and increases cortical excitability for at least 20 min. pcTBS consisted of three pulses at 50 Hz (i.e., 60 ms) repeated 400 times at intervals of 200 ms (a total of 1,200 pulses in 1 min and 44 s)
Sponsors & Collaborators
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 85 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-01
- Primary Completion
- 2028-12-31
- Completion
- 2029-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
NCT02549534 ·Status: COMPLETED
-
Diagnostic Performance of Contrast-Enhanced Mammography
NCT06713915 ·Status: NOT_YET_RECRUITING
-
Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer Survivors
NCT01018108 ·Status: COMPLETED ·Phase: PHASE1
-
Neuromodulation of Central Sensory Integration to Improve Postural Control
NCT06610617 ·Status: COMPLETED ·Phase: NA
-
Digital Mind-Body Therapy for Neoadjuvant Breast Cancer
NCT07541664 ·Status: RECRUITING ·Phase: NA
-
The Mamma HiToP Study
NCT06132776 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast Cancer
NCT03190083 ·Status: COMPLETED ·Phase: NA
-
Surveillance Imaging Modalities for Breast Cancer Assessment
NCT02212834 ·Status: COMPLETED
-
Simulated Screening Study for Breast Imaging
NCT01807754 ·Status: COMPLETED
-
Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer
NCT03650803 ·Status: COMPLETED ·Phase: NA
-
Photobiomodulation for Prevention of Radiodermatitis in Women With Breast Cancer Undergoing Adjuvant Radiotherapy
NCT05535452 ·Status: UNKNOWN ·Phase: NA
-
The Diagnostic Efficacy of Computer-Aided Detection (CAD) in Full-Field Digital Mammography (FFDM)- A Prospective Study
NCT00173303 ·Status: UNKNOWN
-
Photobiomodulation for Breast Cancer Radiodermatitis
NCT04059809 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)
NCT01992432 ·Status: ACTIVE_NOT_RECRUITING
-
The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
NCT01023802 ·Status: COMPLETED
-
Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer
NCT00743314 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality
NCT01024114 ·Status: WITHDRAWN
-
Efficacy of Pulsed Electromagnetic Field Therapy on Acute Radiodermatitis in Breast Cancer Patients
NCT06003764 ·Status: COMPLETED ·Phase: NA
-
Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography
NCT00722059 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Late-term Effects of Hypofractionated Chest Wall and Regional Nodal Irradiation in Patients With Breast Cancer
NCT04175821 ·Status: COMPLETED
-
Postoperative Radiation of Patients With Breast Cancer in Extreme Hypofractionation.
NCT05452083 ·Status: NOT_YET_RECRUITING
-
Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer
NCT04822597 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients
NCT01639417 ·Status: COMPLETED
-
Evaluation of the Efficacy of Digital Breast Tomosynthesis Imaging
NCT01373671 ·Status: COMPLETED ·Phase: NA
-
Binaural Music Study
NCT05240196 ·Status: COMPLETED ·Phase: NA